Losartan potassium - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for losartan potassium and what is the scope of patent protection?

Losartan potassium is the generic ingredient in two branded drugs marketed by Organon, Aiping Pharm Inc, Alembic Pharms Ltd, Apotex, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for losartan potassium. Forty-seven suppliers are listed for this compound.

Summary for losartan potassium

US Patents:	0
Tradenames:	2
Applicants:	25
NDAs:	25
Drug Master File Entries:	38
Finished Product Suppliers / Packagers:	47
Raw Ingredient (Bulk) Api Vendors:	139
Clinical Trials:	86
Patent Applications:	3,824
Drug Prices:	Drug price trends for losartan potassium
Drug Sales Revenues:	Drug sales revenues for losartan potassium
What excipients (inactive ingredients) are in losartan potassium?	losartan potassium excipients list
DailyMed Link:	losartan potassium at DailyMed

See drug prices for losartan potassium

Drug Sales Revenue Trends for losartan potassium

See drug sales revenues for losartan potassium

Recent Clinical Trials for losartan potassium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Gadjah Mada University	Phase 1/Phase 2
Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Steadman Philippon Research Institute	Phase 2

See all losartan potassium clinical trials

Pharmacology for losartan potassium

Drug Class	Angiotensin 2 Receptor Blocker
Mechanism of Action	Angiotensin 2 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for losartan potassium

Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for losartan potassium

C09CA	Angiotensin II receptor blockers (ARBs), plain
C09C	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for losartan potassium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	218551-001	Jun 4, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Macleods Pharms Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	202230-001	May 30, 2012	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lupin Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	078232-003	Oct 6, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	091590-003	Oct 6, 2010		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alembic Pharms Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090428-003	Oct 6, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for losartan potassium

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998	⤷ Sign Up	⤷ Sign Up
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998	⤷ Sign Up	⤷ Sign Up
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995	⤷ Sign Up	⤷ Sign Up
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995	⤷ Sign Up	⤷ Sign Up
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.